π΅οΈ Genworth Financial Inc ($GNW)
SEC insider & ownership activity, last 12 months Β· CIK 1276520 Β· every row links its SEC filing
Over the last 12 months insiders sold $2.8M with no open-market buying against it. Thomas J. McInerney sold $1.3M in discretionary trades (DecβMay). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) Β· 4 sellers, $2.8M (5 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Thomas J. McInerney | 0 | β | 2 | $1.3M | May 22, 2026 |
| Gupta Rohit | 0 | β | 1 | $750K | Aug 27, 2025 |
| Robert P. Restrepo Jr. | 0 | β | 1 | $456K | May 22, 2026 |
| Gregory S. Karawan | 0 | β | 1 | $340K | Nov 24, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Donald Smith & Co., Inc. | 6.6% | 13G | May 13, 2026 | filing β | |
| DSCO Value Fund, L.P. | 6.6% | 13G | May 13, 2026 | filing β | |
| Vanguard Portfolio Management | 6.1% | 13G | Apr 29, 2026 | filing β | |
| Vanguard Capital Management | 5.4% | 13G | Apr 29, 2026 | filing β |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Robert P. Restrepo Jr. | $456K | May 22, 2026 | filing β |
| Thomas J. McInerney | $927K | May 22, 2026 | filing β |
| Thomas J. McInerney | $346K | Dec 2, 2025 | filing β |
| Gregory S. Karawan | $340K | Nov 24, 2025 | filing β |
| Rohit Gupta | $749K | Aug 27, 2025 | filing β |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jul 7, 2026 | filing β |
| Shareholder vote (5.07) | May 20, 2026 | filing β |
| Earnings (2.02) | May 5, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing β |
| Earnings (2.02) | Feb 23, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Feb 23, 2026 | filing β |
| Earnings (2.02) | Feb 3, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Feb 3, 2026 | filing β |
| Earnings (2.02) | Nov 5, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing β |
| Earnings (2.02) | Jul 30, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Jul 30, 2025 | filing β |